4.3 Editorial Material

Hysterectomy with ovarian conservation: is there a downside?

Journal

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/GME.0000000000001094

Keywords

-

Funding

  1. AbbVie
  2. Allergan
  3. Ferring Pharmaceutical
  4. Bayer
  5. Palatin

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available